Used in the synthesis of anticonvulsant drugs as a key intermediate, particularly in the development of hydantoin-based medications for treating epilepsy. It plays a key role in modifying the structure of nootropic and neuroprotective agents due to its ability to interact with neuronal targets involved in seizure regulation. Its chiral center allows for selective binding, enhancing drug efficacy and reducing side effects. Also explored in the development of prodrugs for improved bioavailability in central nervous system therapies.